Cesca Therapeutics Inc(KOOL)- NASDAQ
  • Jul. 16, 2013, 7:52 AM

    ThermoGenesis (KOOL) will merge with privately held TotipotentRx, a cell-based regenerative medicine company. KOOL will issue 12.491M shares worth some $18.6M to TotipotentRx. The deal is expected to close in Q4 and will be "transformative," in the words of KOOL CEO Matthew Plavan. (PR)

    | Jul. 16, 2013, 7:52 AM | 1 Comment